Horvath Keith J, Todd Kieran, Arayasirikul Sean, Cotta Nicholas W, Stephenson Rob
Department of Psychology, San Diego State University, San Diego, California.
Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
Transgend Health. 2019 Oct 1;4(1):217-221. doi: 10.1089/trgh.2019.0027. eCollection 2019.
We use quantitative and qualitative data from two ongoing studies to describe pre-exposure prophylaxis (PrEP) awareness, willingness to use PrEP, barriers to facilitators of PrEP uptake, and PrEP use among 15- to 24-year-old transgender and gender nonbinary (TGNB) youth. Most youth were aware of PrEP, but only one participant across both studies reported current use. Uncertainty about willingness to take PrEP may be related to general (e.g., medication cost) and trans-specific (e.g., PrEP-hormone interactions) concerns. Intensified and sustained efforts are needed to engage TGNB youth along the PrEP continuum and the impact of new PrEP administration and dosing options should be examined for TGNB youth.
我们使用两项正在进行的研究中的定量和定性数据，来描述15至24岁的跨性别和性别非二元（TGNB）青年对暴露前预防（PrEP）的认知、使用PrEP的意愿、PrEP使用的促进因素和障碍，以及PrEP的使用情况。大多数青年知晓PrEP，但两项研究中只有一名参与者报告目前正在使用。对服用PrEP意愿的不确定性可能与一般（如药物成本）和跨性别特定（如PrEP与激素的相互作用）的担忧有关。需要加大力度并持续努力，让TGNB青年参与到PrEP连续过程中，并且应该研究新的PrEP给药和剂量选择对TGNB青年的影响。
